Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine, covering 2026-07-30 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Results: A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults [Phase 1]